Last 12 months
Inside the activity.
4 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 4 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2022 Filed Feb 28, 2022 22:34 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 5,900 | $1.44 | $8,496.00 |
DisclosureSEC source: 0001209191-22-013725 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 262,674 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.44, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4. Read SEC document |
| February 24, 2022 Filed Feb 28, 2022 17:26 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 11,000 | $1.43 | $15,730.00 |
DisclosureSEC source: 0001209191-22-013475 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,244,206 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.43 to $1.45, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 16:56 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 17,800 | $1.44 | $25,632.00 |
DisclosureSEC source: 0001209191-22-012064 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,233,206 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.45, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 22, 2022 Filed Feb 28, 2022 22:34 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 500 | $1.42 | $710.00 |
DisclosureSEC source: 0001209191-22-013725 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,774 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 16:56 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.43 | $2,145.00 |
DisclosureSEC source: 0001209191-22-012064 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,215,406 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.45, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 18:01 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 6,500 | $1.43 | $9,295.00 |
DisclosureSEC source: 0001209191-22-011119 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,213,906 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.42 to $1.47, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 18:01 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.47 | $1,470.00 |
DisclosureSEC source: 0001209191-22-011119 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,207,406 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.47, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 20:01 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 6,000 | $1.45 | $8,700.00 |
DisclosureSEC source: 0001209191-22-010142 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,206,406 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.43 to $1.45, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 14, 2022 Filed Feb 16, 2022 20:01 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 6,000 | $1.45 | $8,700.00 |
DisclosureSEC source: 0001209191-22-010142 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200,406 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.44 to $1.49, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 11, 2022 Filed Feb 11, 2022 22:00 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 4,000 | $1.49 | $5,960.00 |
DisclosureSEC source: 0001209191-22-008917 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,194,406 F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 22:00 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,000 | $1.45 | $4,350.00 |
DisclosureSEC source: 0001209191-22-008917 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,190,406 F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 09, 2022 Filed Feb 11, 2022 22:00 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 23,500 | $1.45 | $34,075.00 |
DisclosureSEC source: 0001209191-22-008917 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,187,406 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.49, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 08, 2022 Filed Feb 9, 2022 18:57 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,250 | $1.49 | $4,842.50 |
DisclosureSEC source: 0001209191-22-007990 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,163,906 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.50, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 07, 2022 Filed Feb 9, 2022 18:57 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 5,250 | $1.47 | $7,717.50 |
DisclosureSEC source: 0001209191-22-007990 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,160,656 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.43 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 04, 2022 Filed Feb 7, 2022 19:00 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 7,000 | $1.43 | $10,010.00 |
DisclosureSEC source: 0001209191-22-007395 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,155,406 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.32 to $1.50, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 19:00 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 6,250 | $1.40 | $8,750.00 |
DisclosureSEC source: 0001209191-22-007395 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,148,406 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.36 to $1.44, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 21:33 UTC |
Lui Alfred Fu KongDirector
|
PurchaseCommon stock, $0.001 par value | 10,000 | $1.58 | $15,800.00 |
DisclosureSEC source: 0001209191-22-001710 · doc4.xml · nonDerivative · entry 1 Lui Alfred Fu Kong · CIK 0001877239 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.65, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| December 31, 2021 Filed Jan 3, 2022 21:22 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 7,000 | $1.58 | $11,060.00 |
DisclosureSEC source: 0001209191-22-000164 · doc4.xml · nonDerivative · entry 4 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,142,156 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.65, inclusive. F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 30, 2021 Filed Jan 3, 2022 21:22 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 6,800 | $1.56 | $10,608.00 |
DisclosureSEC source: 0001209191-22-000164 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,135,156 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.52 to $1.65, inclusive. F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 21:22 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,700 | $1.57 | $4,239.00 |
DisclosureSEC source: 0001209191-22-000164 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,128,356 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.55 to $1.60, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnotes (3) and (4) to this Form 4. F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 28, 2021 Filed Jan 3, 2022 21:22 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.60 | $1,600.00 |
DisclosureSEC source: 0001209191-22-000164 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,125,656 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 17:11 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,200 | $1.48 | $1,776.00 |
DisclosureSEC source: 0001209191-21-071358 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,124,656 F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 23, 2021 Filed Dec 28, 2021 17:11 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.50 | $2,250.00 |
DisclosureSEC source: 0001209191-21-071358 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,123,456 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.48 to $1.54, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 22, 2021 Filed Dec 28, 2021 17:11 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 5,000 | $1.48 | $7,400.00 |
DisclosureSEC source: 0001209191-21-071358 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,121,956 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 16:11 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 4,900 | $1.49 | $7,301.00 |
DisclosureSEC source: 0001209191-21-070895 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,116,956 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.49 to $1.50, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 16:11 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,000 | $1.51 | $4,530.00 |
DisclosureSEC source: 0001209191-21-070895 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,112,056 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.51 to $1.60, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 17, 2021 Filed Dec 22, 2021 16:11 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,750 | $1.49 | $4,097.50 |
DisclosureSEC source: 0001209191-21-070895 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,109,056 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.45 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3) and (4) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 17, 2021 Filed Jan 5, 2022 16:52 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 500 | $1.50 | $750.00 |
DisclosureSEC source: 0001209191-22-001426 · doc4.xml · nonDerivative · entry 4 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 1,000 Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 21:12 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 4,000 | $1.54 | $6,160.00 |
DisclosureSEC source: 0001209191-21-070255 · doc4.xml · nonDerivative · entry 4 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,106,306 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.55, inclusive. F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 21:12 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,000 | $1.52 | $4,560.00 |
DisclosureSEC source: 0001209191-21-070255 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,102,306 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.53, inclusive. F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 14, 2021 Filed Dec 17, 2021 21:12 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.52 | $2,280.00 |
DisclosureSEC source: 0001209191-21-070255 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,099,306 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.47 to $1.53, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (2) and in footnotes (3) and (4) to this Form 4. F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 13, 2021 Filed Jan 5, 2022 16:52 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 500 | $1.52 | $760.00 |
DisclosureSEC source: 0001209191-22-001426 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Roth IRA FBO Willis C. Lee Disclosed balance after: 500 Read SEC document |
| December 10, 2021 Filed Dec 17, 2021 21:12 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.57 | $1,570.00 |
DisclosureSEC source: 0001209191-21-070255 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,097,806 F1 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 10, 2021 Filed Jan 5, 2022 16:52 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 200 | $1.74 | $348.00 |
DisclosureSEC source: 0001209191-22-001426 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,274 Read SEC document |
| December 09, 2021 Filed Dec 10, 2021 18:19 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 2,000 | $1.69 | $3,380.00 |
DisclosureSEC source: 0001209191-21-068959 · doc4.xml · nonDerivative · entry 4 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,096,806 F5 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.60 to $1.78, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 08, 2021 Filed Dec 10, 2021 18:19 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,200 | $1.58 | $1,896.00 |
DisclosureSEC source: 0001209191-21-068959 · doc4.xml · nonDerivative · entry 3 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,094,806 F4 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.56 to $1.65, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 07, 2021 Filed Dec 10, 2021 18:19 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,900 | $1.55 | $2,945.00 |
DisclosureSEC source: 0001209191-21-068959 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,093,606 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.56, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 06, 2021 Filed Dec 10, 2021 18:19 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,500 | $1.49 | $2,235.00 |
DisclosureSEC source: 0001209191-21-068959 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,091,706 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (3), (4) and (5) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 03, 2021 Filed Dec 6, 2021 21:19 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 1,000 | $1.55 | $1,550.00 |
DisclosureSEC source: 0001209191-21-068106 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,090,206 F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 03, 2021 Filed Jan 5, 2022 16:52 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 500 | $1.54 | $770.00 |
DisclosureSEC source: 0001209191-22-001426 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,074 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.55, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). Read SEC document |
| December 02, 2021 Filed Dec 6, 2021 21:19 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 3,400 | $1.53 | $5,202.00 |
DisclosureSEC source: 0001209191-21-068106 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,089,206 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.66, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1). F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| December 01, 2021 Filed Dec 2, 2021 18:58 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 5,750 | $1.72 | $9,890.00 |
DisclosureSEC source: 0001209191-21-067479 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,085,806 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.63 to $1.92, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 30, 2021 Filed Nov 30, 2021 22:45 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 15,500 | $1.50 | $23,250.00 |
DisclosureSEC source: 0001209191-21-067167 · doc4.xml · nonDerivative · entry 3 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 228,394 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.39 to $1.53, inclusive. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 18:58 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 35,600 | $1.51 | $53,756.00 |
DisclosureSEC source: 0001209191-21-067479 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,080,056 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.40 to $1.53, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 22:45 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 15,705 | $1.47 | $23,086.35 |
DisclosureSEC source: 0001209191-21-067167 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 212,894 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.50, inclusive. Read SEC document |
| November 29, 2021 Filed Nov 30, 2021 17:47 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 16,000 | $1.45 | $23,200.00 |
DisclosureSEC source: 0001209191-21-067094 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,044,456 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.24 to $1.50, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 22:45 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 24,328 | $1.45 | $35,275.60 |
DisclosureSEC source: 0001209191-21-067167 · doc4.xml · nonDerivative · entry 1 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 197,189 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.28 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4. Read SEC document |
| November 26, 2021 Filed Nov 30, 2021 17:47 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 56,009 | $1.41 | $78,972.69 |
DisclosureSEC source: 0001209191-21-067094 · doc4.xml · nonDerivative · entry 1 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,028,456 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.21 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnote (3) to this Form 4. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 24, 2021 Filed Nov 26, 2021 21:06 UTC |
Niihara YutakaDirector · Chairman and CEO · 10% owner
|
PurchaseCommon stock, $0.001 par value | 19,300 | $1.34 | $25,862.00 |
DisclosureSEC source: 0001209191-21-066923 · doc4.xml · nonDerivative · entry 2 Niihara Yutaka · CIK 0001517691 · Director · Chairman and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,972,447 F3 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.22 to $1.35, inclusive. F2 · ownership.direct: The shares shown include shares owned jointly with Soomi Niihara, the reporting person's wife. Read SEC document |
| November 24, 2021 Filed Nov 26, 2021 21:05 UTC |
LEE WILLIS CDirector · Vice Chairman & COO
|
PurchaseCommon stock, $0.001 par value | 34,500 | $1.34 | $46,230.00 |
DisclosureSEC source: 0001209191-21-066920 · doc4.xml · nonDerivative · entry 2 LEE WILLIS C · CIK 0001517775 · Director · Vice Chairman & COO 10b5-1 filing: Not disclosed Ownership: Indirect · By Fidelity Traditional IRA FBO Willis C. Lee Disclosed balance after: 172,861 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.35, inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.